2,222
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety

, , , , , & show all
Pages 161-168 | Received 23 Dec 2013, Accepted 20 Mar 2014, Published online: 23 Apr 2014

References

  • Agargun MY, Kara H, Anlar O. 1996. The validity and reliability of the Pittsburgh Sleep Quality Index. Turk Psikiyatri Derg 7: 107–115.
  • Agargun MY, Kara H, Bilici M, Cilli AS, Telci M, Semiz UB, et al. 1999. The Van Dream Anxiety Scale: a subjective measure of dream anxiety in nightmare sufferers. Sleep Hypn 4:204–211.
  • Bender BG, Berning S, Dudden R, Milgrom H, Tran ZV. 2003. Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis. Allergy Clin Immuno 111:770–776.
  • Boyle J, Eriksson M, Stanley N, Fujita T, Kumagi Y. 2006. Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects. Curr Med Res Opin 22:1343–1351.
  • Brown RE, Stevens DR, Haas HL. 2001. The physiology of brain histamine. Prog Neurobiol 63:637–672.
  • Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. 1989. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213.
  • Church MK, Maurer M, Simons FE, Bindslev-Jensen C, Cauwenberge P, Bousquet J, et al. 2010. Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy 65:459–466.
  • Crownover BK, Jamieson B, Mott TF. 2004. First- or second-generation antihistamines: which are more effective at controlling pruritus?J Fam Pract 53:742–744.
  • Grundmann S, Ständer S. 2011. Chronic pruritus: clinics and treatment. Ann Dermatol 23:1–10.
  • Haas H, Panula P. 2003. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4: 121–130.
  • Herman SM, Vender RB. 2003. Antihistamines in the treatment of dermatitis. J Cutan Med Surgb 7:467–473.
  • Hindmarch I, Shamsi Z. 2001. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers. Curr Med Res Opin 17:273–281.
  • Izci B, Ardic S, Firat H, Sahin A, Altinors M, Karacan I. 2008. Reliability and validity studies of the Turkish version of the Epworth sleepiness scale. Sleep Breath 12:161–168.
  • Johns MW. 1991. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545.
  • Kay GG, Berman B, Mockoviak SH, Morris CE, Reeves D, Starbuck V, et al. 1997a. Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance. Arch Intern Med 157:2350–2356.
  • Kay GG, Harris AG. 1999. Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation. Clin Exp Allergy 29:147–150.
  • Kay GG, Plotkin KE, Quig MB, Starbuck VN, Yasuda S. 1997b. Sedating effects of AM/PM antihistamine dosing with evening chlorpheniramine and morning terfenadine. Am J Man Care 3:1843–1848.
  • Lingjaerde O, Ahlfors U, Bech P, Dencker S, Elgen K. 1987. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 334:1–100.
  • Liu YW, Li J, Ye JH. 2010. Histamine regulates activities of neurons in the ventrolateral preoptic nucleus. J Physiol 588: 4103–4116.
  • Mann RD, Pearce GL, Dunn N, Shak S. 2000. Sedation with “non­sedating” antihistamines: four prescription­event monitoring studies in general practice. Gen Pract BMJ 320:1184–1187.
  • McNair D, Lorr M, Droppleman L. 1981. Profile of mood states manual. San Diego: Educational and Industrial Testing.
  • O’Donoghue M, Tharp MD. 2005. Antihistamines and their role as antipruritics. Dermatol Ther 18:333–340.
  • Onodera K, Yamatodani A, Watanabe T, Wada H. 1994. Neuropharmacology of the histaminergic neuron system in thebrain and its relationship with behavioral disorders. Prog Neurobiol 42: 685–702.
  • Presa IJ. 1999. H1 antihistamines: a review. Alergol Immunol Clin 14:300–312.
  • Ramaekers JG, Uiterwijk MM, O’Hanlon JF. 1992. Effects of loratadine and cetirizine on actual driving and psychometric test performance and EEG during driving. Eur J Clin Pharmacol 42: 363–369.
  • Reamy B, Bunt C, Fletcher S. 2011. A diagnostic approach to pruritus. Am Fam Physician 84:195–202.
  • Riedel WJ, Ramaekers G, Uiterwijk MM, O’Hanlon JF. 1990. Higher doses of terfenadine and loratadine: acute and subchronic effects on psychomotor and actual driving performance. Maastricht: Institute for Drugs, Safety and Behavior, University of Limburg.
  • Rojas-Zamorano JA, Esqueda-Leon E, Jimenez-Anguiano A, Cintra-Mc Glone L, Mendoza Melendez MA, Velazquez MJ. 2009. The H1 histamine receptor blocker, chlorpheniramine, completely prevents the increase in REM sleep induced by immobilization stres in rats. Pharmacol Biochem Behav 9:291–294.
  • Salmun LM, Gates D, Scharf M, Greiding L, Ramon F, Heithoff K. 2000. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday. Clin Ther 22:573–582.
  • Schweitzer PK, Muehlbach MJ, Walsh JK. 1994. Sleepiness and performance during three-day administration of cetirizine or diphenhydramine. J Allergy Clin Immunol 94:716–724.
  • Selvi Y, Gulec M, Aydin A, Besiroglu L. 2011. Psychometric evaluation of the Turkish language version of the Profile of Mood States (POMS). J Mood Dis 1:152–161.
  • Simons FE. 2004. Advances in H1-antihistamines. N Engl J Med 351:2203–2217.
  • Ständer S, Weisshaar E, Mettang T, Szepietowski JC, Carstensm E, Ikoma A, et al. 2007. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 87:291–294.
  • Tashiro M, Sakurada Y, Iwabuchi K, Mochizuki H, Kato M. 2004. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. J Clin Pharmacol 44:890–900.
  • Theunissen EL, Vermeeren A, Ramaekers JG. 2006. Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. Br J Clin Pharmacol 61: 79–86.
  • Weisshaar E, Szepietowski JC, Darsow U, Misery L, Wallengren J, Mettang T, et al. 2011. EDF-Guidelines for Chronic Pruritus In cooperation with the European Academy of Dermatology and Venereology (EADV) and the Union Européenne des Médecins Spécialistes (UEMS).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.